Allium hookeri root extract regulates asthmatic changes through immunological modulation of Th1/Th2‑related factors in an ovalbumin‑induced asthma mouse model

Bok,So‑Hyeon; Seo,Ji‑Hye; Bae,Chun‑Sik; Kang,Bossng; Cho,Seung  Sik; Park,Dae‑Hun

doi:10.3892/mmr.2019.10560

Allium hookeri root extract regulates asthmatic changes through immunological modulation of Th1/Th2‑related factors in an ovalbumin‑induced asthma mouse model

Authors:
- So‑Hyeon Bok
- Ji‑Hye Seo
- Chun‑Sik Bae
- Bossng Kang
- Seung Sik Cho
- Dae‑Hun Park
View Affiliations

Affiliations: College of Oriental Medicine, Dongshin University, Naju, Jeonnam 58245, Republic of Korea, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea, Department of Emergency Medicine, College of Medicine, Hanyang University, Guri, Gyunggi 11923, Republic of Korea, College of Pharmacy, Mokpo National University, Muan, Jeonnam 58554, Republic of Korea
Published online on: August 6, 2019 https://doi.org/10.3892/mmr.2019.10560
Pages: 3215-3223
Copyright: © Bok et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In 2013, WHO estimated that approximately 235 million people suffered from asthma worldwide. Asthma is a hyper responsive disorder, which is related to an imbalance between the T‑helper type 1 and 2 cells (henceforth, Th1 and Th2, respectively). Allium hookeri is a plant that is widely used for culinary purposes and also in traditional Asian medicine. The present study was conducted to elucidate the anti‑asthmatic effects and mechanism of action of A. hookeri root extracts (AHRE) in an ovalbumin (OVA)‑induced asthma mouse model. The mice were divided into five groups, namely, the control, the OVA‑treated group, the dexamethasone‑treated group, the 30 mg/kg AHRE‑treated group, and the 300 mg/kg AHRE‑treated group. The total WBC count and the differential cell count in the bronchoalveolar fluid, the level of serum IgE, the histopathological changes in the lung, and changes in the cell surface molecules, the asthma‑related cytokine levels, and Th cell transcription factors were evaluated. AHRE significantly ameliorated asthmatic changes, such as the total WBC count, eosinophil count, and the level of IgE; in addition, it reduced mucus hypersecretion, epithelial hyperplasia, and eosinophil infiltration in the lungs. AHRE significantly inhibited the expression of CD68+ cells and MHC class II+ molecules, Th1 cell transcription factor (T‑bet) activation, Th2 cell transcription factor (GATA‑3) activation, and TNF‑α in the lung tissue. Furthermore, it suppressed cell surface molecules, such as CD4+and CD8+; Th1‑related cytokines, such as IFN‑γ and IL‑12p40; Th2‑related cytokines, such as IL‑4 and IL‑5; and Th17‑related cytokines, such as IL‑6 and TNF‑α, in a dose‑dependent manner. Thus, AHRE may be considered a promising anti‑asthmatic drug.

View Figures

View References

1	World Health Organization. Asthma Fact Sheet No 307. 2013, . https://www.who.int/en/news-room/fact-sheets/detail/asthma31–August. 2017
2	Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin SL, Globe G and Sullivan PW: Asthma control in the United States, 2008–2010: Indicators of poor asthma control. J Allergy Clin Immunol. 133:1579–1587. 2014. View Article : Google Scholar : PubMed/NCBI
3	Kay AB: Allergy and allergic diseases. First of two parts. N Engl J Med. 344:30–37. 2000. View Article : Google Scholar
4	American Academy of Allergy, AsthmaImmunology and Asthma statistics. 14–April. 2019, http://www.aaaai.org/about-the-aaaai/newsroom/asthma-statistics.aspx
5	Stirling RG and Chung KF: New immunological approaches and cytokine targets in asthma and allergy. Eur Respir J. 16:1158–1174. 2000. View Article : Google Scholar : PubMed/NCBI
6	Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG and Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:655–669. 2000. View Article : Google Scholar : PubMed/NCBI
7	Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G, Guo L, Yagi R, Yamane H, Punkosdy G, et al: The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity. 37:660–673. 2012. View Article : Google Scholar : PubMed/NCBI
8	Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G and Romagnani S: Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 177:1199–1204. 1993. View Article : Google Scholar : PubMed/NCBI
9	Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, et al: Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med. 195:1433–1444. 2002. View Article : Google Scholar : PubMed/NCBI
10	Mosmann TR and Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:145–173. 1989. View Article : Google Scholar : PubMed/NCBI
11	Barnes PJ: Immunology of asthma and chronic obstructive pulmonary disease. Nat Immunol. 8:183–192. 2008. View Article : Google Scholar
12	Yagi R, Zhu J and Paul WE: An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol. 23:415–420. 2011. View Article : Google Scholar : PubMed/NCBI
13	Rincon M and Irvin CG: Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 8:1281–1290. 2012. View Article : Google Scholar : PubMed/NCBI
14	Hershey GK: IL-13 receptors and signaling pathways: An evolving web. J Allergy Clin Immunol. 111:677–690; quiz 691. 2003. View Article : Google Scholar : PubMed/NCBI
15	Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, Tarallo A, Stripp B, Whitsett J and Flavell RA: Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA. 93:7821–7825. 1996. View Article : Google Scholar : PubMed/NCBI
16	Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science. 282:2258–2261. 1998. View Article : Google Scholar : PubMed/NCBI
17	Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y and Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 103:779–788. 1999. View Article : Google Scholar : PubMed/NCBI
18	Hamid Q, Shannon J and Martin J: Physiologic basis of respiratory diseaseCytokines and Chemokines in Aasthma: An Overview. Tulic MK, Fiset PO, Muller Z and Hamid Q: BC Decker Inc.; Hamilton: pp. 453–467. 2005
19	Mishra A, Yao X and Levine SJ: From bedside to bench to clinic trials: Identifying new treatments for severe asthma. Dis Model Mech. 6:877–888. 2013. View Article : Google Scholar : PubMed/NCBI
20	Wise J: Corticosteroids for asthma may suppress growth in children in first year of treatment, researchers say. BMJ. 349:g46232014. View Article : Google Scholar : PubMed/NCBI
21	Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F and Russo E: Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 4 (Suppl 1):S94–S98. 2013. View Article : Google Scholar : PubMed/NCBI
22	Bang MA, Seo JH, Seo JW, Jo GH, Jung SK, Yu R, Park DH and Park SJ: Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines. PLoS One. 10:e01175242015. View Article : Google Scholar : PubMed/NCBI
23	Seo JW, Cho SC, Park SJ, Lee EJ, Lee JH, Han SS, Pyo BS, Park DH and Kim BH: 1′-Acetoxychavicol acetate isolated from Alpinia galanga ameliorates ovalbumin-induced asthma in mice. PLoS One. 8:e564472013. View Article : Google Scholar : PubMed/NCBI
24	Seo JH, Bang MA, Kim G, Cho SS and Park DH: Erythronium japonicum attenuates histopathological lung abnormalities in a mouse model of ovalbumin-induced asthma. Int J Mol Med. 37:1221–1228. 2016. View Article : Google Scholar : PubMed/NCBI
25	Singh KB and Nongmaithem M: Antioxidant and free radical scavenging potential of Allium hookeri Thwaites roots extract studied using in vitro models council for innovative research. J Adv Biol. 4:276–285. 2014.
26	Li R, Wang YF, Sun Q and Hu HB: Chemical composition and antimicrobial activity of the essential oil from Allium hookeri consumed in Xishuangbanna, southwest China. Nat Prod Commun. 9:863–864. 2014.PubMed/NCBI
27	Bae GC and Bae DY: The anti-inflammatory effects of ethanol extract of Allium hookeri cultivated in South Korea. Korea J Herbol. 27:55–61. 2012. View Article : Google Scholar
28	Kim HY, Nam SY, Hong SW, Kim MJ, Jeong HJ and Kim HM: Protective effects of rutin through regulation of vascular endothelial growth factor in allergic rhinitis. Am J Rhinol Allergy. 29:e87–e94. 2015. View Article : Google Scholar : PubMed/NCBI
29	Ariza A, Fernandez TD, Doña I, Aranda A, Blanca-Lopez N, Melendez L, Canto G, Blanca M, Torres MJ and Mayorga C: Basophil activation after nonsteroidal anti-inflammatory drugs stimulation in patients with immediate hypersensitivity reactions to these drugs. Cytometry A. 85:400–407. 2014. View Article : Google Scholar : PubMed/NCBI
30	National Asthma Education and Prevention Program: National asthma education and prevention program. Expert panel report: Guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol. 110 (Suppl 5):S141–S219. 2002.PubMed/NCBI
31	Galli SJ, Tsai M and Piliponsky AM: The development of allergic inflammation. Nature. 454:445–454. 2008. View Article : Google Scholar : PubMed/NCBI
32	Zhu J, Message SD, Qiu Y, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, et al: Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest. 145:1219–1229. 2014. View Article : Google Scholar : PubMed/NCBI
33	Mantovan A, Garlanda C and Locati M: Macrophage diversity and polarization in atherosclerosis: A question of balance. Arter Thromb Vasc Biol. 29:1419–1423. 2009. View Article : Google Scholar
34	Magnan A, van Pee D, Bongrand P and Vervloet D: Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy. 53:1092–1095. 1998. View Article : Google Scholar : PubMed/NCBI
35	Gosset P, Tillie-Leblond I, Oudin S, Parmentier O, Wallaert B, Joseph M and Tonnel AB: Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. J Allergy Clin Immunol. 103:289–297. 1999. View Article : Google Scholar : PubMed/NCBI
36	Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J and Lechler R: Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol. 20:1893–1897. 1990. View Article : Google Scholar : PubMed/NCBI
37	Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G and Lechler R: Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int. 53:679–689. 1998. View Article : Google Scholar : PubMed/NCBI
38	Gaspari AA, Jenkins MK and Katz SI: Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol. 141:2216–2220. 1988.PubMed/NCBI
39	Jang JY, Lee MJ, You BR, Jin JS, Lee SH, Yun YR and Kim HJ: Allium hookeri root extract exerts anti-inflammatory effects by nuclear factor-kB down-regulation in lipopolysaccharide-induced RAW264.7 cells. BMC Complement Altern Med. 17:1262017. View Article : Google Scholar : PubMed/NCBI
40	Kim JE, Seo JH, Bae MS, Bae CS, Yoo JC, Bang MA, Cho SS and Park DH: Antimicrobial Constituents from Allium hookeri root. Nat Prod Commun. 11:237–238. 2016.PubMed/NCBI
41	Kim JE, Park KM, Lee SY, Seo JH, Yoon IS, Bae CS, Yoo JC, Bang MA, Cho SS and Park DH: Anti-inflammatory effect of Allium hookeri on carrageenan-induced air pouch mouse model. PLoS One. 12:e01903052017. View Article : Google Scholar : PubMed/NCBI
42	Xu F, Wang F, Wen T, Sang W, He X, Li L and Zeng N: Protective effect of cinnamic acid in endotoxin-poisoned mice. Phytother Res. 31:1946–1953. 2017. View Article : Google Scholar : PubMed/NCBI